Facebook
Twitter
LinkedIn
Forward
Learn more about Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2022
This course offers Live (in-person) and Livestream (virtual) attendance options
Course Directors: Tanios S. Bekaii-Saab, M.D., Mitesh J. Borad, M.D., Sean P. Cleary, M.D., and G. Dan Duda, D.M.D., Ph.D.
October 21 - 22, 2022 - Wynn Las Vegas, Las Vegas, Nevada
 | In collaboration with the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO) |
Nationally and internationally renowned faculty provide a state-of-the-art update on the latest treatment options for patients with hepato-pancreatico-biliary cancers. The symposium is designed to provide a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. The symposium emphasizes implementation of these approaches into clinical practice.
LIVE (in-person) attendees must comply with all live course requirements and guidelines and applicable state and local COVID-19 travel restrictions, guidance and resources.
Please note that LIVE course attendees must:
- Complete COVID-19 testing of any kind (home tests are acceptable) and received a negative test result within 72 hours of the event start date OR
- A positive COVID-19 test result of any kind was received within the past 90 days, it has been at least 10 days since COVID-19 infection, and you are currently asymptomatic.
- You must be logged in to ce.mayo.edu to complete your attestation. (Attestations can be completed starting Tuesday, October 18, 2022)
Learners who do not fulfill the above requirements will be unable to attend this live (in-person) event.
Requirements and guidelines may be amended as CDC, public health and other relevant guidance are adjusted.
Target Audience
This course is intended for surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, physician assistants, nurse practitioners, registered nurses, oncology pharmacists, oncology nurses and clinical research personnel. Specialties include: medical oncology, hematology, gastroenterology, radiation oncology, surgical oncology, pathology, radiology, and laboratory research science.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Describe innovative options for patients with pancreas, liver and biliary cancers with limited oligometastatic disease.
- Identify current and emerging strategies for early diagnosis and surveillance of liver cancer.
- Identify patients suitable for a liver transplantation, surgical resection, radiation therapy, or other loco-regional approaches.
- Integrate novel molecularly-targeted, as well as immune-based, therapeutic strategies in clinical care and clinical trial participation.
- Recognize the appropriate regimen for first and second line therapy in treating advanced pancreatic cancer, liver and biliary cancer.
- Describe the latest state of the science in pancreatic cancer, liver and biliary cancer.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Click here to view Program Schedule on mobile
We apologize, but due to high interest in the HPB course, the group room block is sold out.
Mayo Clinic is closely monitoring COVID-19 prevalence and may adjust live course attendance limits as necessitated by CDC, public health and other relevant guidelines. Attendees are asked to comply with all live course and conference guidelines.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Course Directors
Tanios S. Bekaii-Saab, M.D.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Mayo Clinic
Phoenix, Arizona
Mitesh J. Borad, M.D.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Mayo Clinic
Phoenix, Arizona
Sean P. Cleary, M.D.
Professor of Surgery, Mayo Clinic College of Medicine and Science
Division Chair, Hepatobiliary/Pancreatic Surgery
Mayo Clinic
Rochester, Minnesota
G. Dan Duda, DMD, PhD, FAIMBE, FAAAS
Director of Translational Research in GI Radiation Oncology,
Massachusetts General Hospital
Investigator, Edwin L. Steele Laboratories for Tumor Biology,
Massachusetts General Hospital Research Institute
Associate Professor of Tumor Biology, Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts
Guest Faculty
Mehmet Akce, M.D.
The Kirklin Clinic of UAB Hospital
Birmingham, Alabama
Anthony B. El-Khoueiry, M.D.
Associate Director, Clinical Research
University of Southern California
Norris Comprehensive Cancer Center
Los Angeles, California
Bassel El-Rayes, M.D.
Deputy Director
O’Neal Cancer Center, University of Alabama
Birmingham, Alabama
Richard S. Finn, M.D.
Professor of Medicine
Geffen School of Medicine
UCLA Division of Hematology/Oncology
Santa Monica, California
James J. Harding, M.D.
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York
Milind Javle, M.D.
Assistant Professor, Roswell Park Cancer Institute, Buffalo
MD Anderson Cancer Center
Houston, Texas
Subam Pant, M.D.
Associate Professor, Department of Gastrointestinal Medical Oncology
MD Anderson Cancer Center
Houston, Texas
Michael Jon Pishvaian, M.D., Ph.D.
Director of Gastrointestinal, Developmental therapeutics and
Clinical Research Programs
Associate Professor of Oncology
Johns Hopkins Medicine
Washington, D.C.
Sanford M. Simon, Ph.D.
Rockefeller University
New York, New York
Matthew John Weiss, M.D.
Professor of Surgery
Deputy Physician-in-Chief, Director of Surgical Oncology
Northwell Health Cancer Institute
New Hyde Park, New York
Mayo Clinic Faculty
Daniel H. Ahn, D.O.
Associate Professor of Medicine
Bashar A. Aqel, M.D.
Associate Professor of Medicine
Christopher (Chris) L. Hallemeier, M.D.
Associate Professor of Radiation Oncology
Lionel A. Kankeu Fonkoua, M.D.
Instructor in Medicine
Nitin N. Katariya, M.D.
Assistant Professor of Surgery
Wen Wee Ma, M.B.B.S.
Professor of Oncology
Douglas L. Riegert-Johnson, M.D.
Assistant Professor of Medicine
Assistant Professor of Medical Genetics
Kumar Sandrasegaran, M.B.Ch.B.
Professor of Radiology
Terence T. Sio, M.D., M.S.
Associate Professor of Radiation Oncology
Mohamad (Bassam) B. Sonbol, M.D.
Assistant Professor of Medicine
Timucin Taner, M.D., Ph.D.
Professor of Surgery
Cornelius A. Thiels, D.O., M.B.A.
Assistant Professor of Health Services Research
Assistant Professor of Surgery
Beau Toskich, M.D.
Associate Professor of Radiology
Mark J. Truty, M.D., M.S.
Associate Professor of Surgery
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this Other activity (Live and Livestream) for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
| Day | Credit |
|---|---|
| Friday | 5.25 |
| Saturday | 4.00 |
ABIM
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 9.25 ABIM
- 9.25 AMA PRA Category 1 Credit™
- 9.25 Attendance
For information regarding exhibit opportunities, please reach out to Kristy Badder.
LIVE (in-person) attendees must comply with all live course requirements and guidelines and applicable state and local COVID-19 travel restrictions, guidance and resources.
Please note that LIVE course attendees must:
- Complete COVID-19 testing of any kind (home tests are acceptable) and received a negative test result within 72 hours of the event start date OR
- A positive COVID-19 test result of any kind was received within the past 90 days, it has been at least 10 days since COVID-19 infection, and you are currently asymptomatic.
- You must be logged in to ce.mayo.edu to complete your attestation. (Attestations can be completed starting Tuesday, October 18, 2022)
Learners who do not fulfill the above requirements will be unable to attend this live (in-person) event.
Requirements and guidelines may be amended as CDC, public health and other relevant guidance are adjusted.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.